Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18
Cohen, Graham L., Coetzee, Corlia, Walton, Cathryn A., Reig Torras, Òscar, Chul Cho, Byoung, McAdam, Georgina, Rojas, Carlos I., Medina Rodríguez, Laura, Papai, Zsuzsanna, Chan, Sze W., Rapoport, Bernardo L., Caglevic, Christian, Yañez Weber, Patricio, Takahashi, Toshiaki, Kurata, Takayasu, Song, Gina, Cohen, Julia W., Akala, Omobolaji O., Khanyile, Richard
Published in European journal of cancer (1990) (09.08.2025)
Published in European journal of cancer (1990) (09.08.2025)
Get full text
Journal Article
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study
Cohen, Graham, Rapoport, Bernardo, Chan, Sze W., Ruff, Paul, Arance, Ana, Mujika Eizmendi, Karmele, Houghton, Baerin, Brown, Michael P., Zielinski, Robert M., Muñoz Couselo, Eva, Lyle, Megan, Anderson, James R., Jain, Lokesh, de Alwis, Dinesh, Lala, Mallika, Akala, Omobolaji, Chartash, Elliot, Jacobs, Conrad
Published in PloS one (12.11.2024)
Published in PloS one (12.11.2024)
Get full text
Journal Article
Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
Heymach, John V., Paz-Ares, Luis, De Braud, Filippo, Sebastian, Martin, Stewart, David J., Eberhardt, Wilfried E.E., Ranade, Anantbhushan A., Cohen, Graham, Trigo, Jose Manuel, Sandler, Alan B., Bonomi, Philip D., Herbst, Roy S., Krebs, Annetta D., Vasselli, James, Johnson, Bruce E.
Published in Journal of clinical oncology (20.11.2008)
Published in Journal of clinical oncology (20.11.2008)
Get full text
Journal Article
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Burtness, Barbara, Greil, Richard, de Castro, Gilberto, Fuereder, Thorsten, Ngamphaiboon, Nuttapong, Wan Ishak, Wan Zamaniah, Hong, Ruey-Long, González Mendoza, René, Zhang, Yayan, Gumuscu, Burak, Boyer, Michael, Hughes, Brett, Rischin, Danny, Taylor, Anne, Burian, Martin, Barrios, Carlos Henrique, de Castro Junior, Dalvaro Oliveira, Franke, Fabio Andre, Girotto, Gustavo, Lima, Iane Pinto Figueiredo, Nicolau, Ulisses Ribaldo, Santos, Lucas, Victorino, Ana-Paula, Chua, Neil, Couture, Felix, Hansen, Aaron, Hilton, John, McCarthy, Joy, Soulieres, Denis, Ascui, Rodrigo, Villanueva, Luis, Kral, Zdenek, Prausova, Jana, Vosmik, Milan, Jurgens, Hannes, Putnik, Kadri, Gruenwald, Viktor, Boukovinas, Ioannis, Psyrri, Amanda, Kwong, Dora, Csoszi, Tibor, Horvai, Geza, Landherr, Laszlo, Szota, Judit, Billan, Salem, Nole, Franco, Fujimoto, Yasushi, Hanai, Nobuhiro, Hara, Hiroki, Shimizu, Yasushi, Sugasawa, Masashi, Takahashi, Shunji, Tanaka, Kaoru, Ueda, Tsutomu, Wan Ishak, Wan Zamaniah, Gonzalez Mendoza, Rene, Buter, Jan, Hoeben, Ann, Bratland, Aase, Querol, John, Regala, Eugenio Emmanuel, Villegas, Ellie May, Karpenko, Andrey, Zarubenkov, Oleg, Cohen, Graham, du Toit, Johanna, Jordaan, Christa, Landers, Gregory, Ruff, Paul, Tabane, Neonyana, Brana, Irene, Iglesias Docampo, Lara, Abel, Edvard, Muratidu, Valentina, Nielsen, Niels, Cristina, Valerie, Rothschild, Sacha, Yang, Muh-Hwa, Yeh, Su-Peng, Ngamphaiboon, Nuttapong, Cicin, Irfan, Ekenel, Meltem, Harrington, Kevin, Ali, Haythem, Anderson, Daniel, Bruce, Justine, Halmos, Balazs, Hegde, Upendra, Khan, Saad, Martincic, Danko, McCune, Steven, Misiukiewicz, Krzysztof, Neupane, Prakash, Nunnink, Johannes, O'Malley, Meaghan, Powell, Steven, Redman, Rebecca, Rella, Vincent, Rocha Lima, Chaio, Wong, Stuart
Published in The Lancet (British edition) (23.11.2019)
Published in The Lancet (British edition) (23.11.2019)
Get full text
Journal Article
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Kowalski, Dariusz M, Cho, Byoung Chul, Lubiniecki, Gregory M, Kush, Debra, Lopes, Gilberto, Adamchuk, Grigory, Ahn, Myung-Ju, Altundag, Ozden, Aoe, Keisuke, Ativitavas, Touch, Beato, Carlos, Bergstrom, Per, Betticher, Daniel, Buddu, Sayeuri, Castro, Hugo, Cay Senler, Filiz, Cerny, Carlos Alexandre Sydow, Chan, Gee-Chen, Chang, Jianhua, Cheng, Susanna, Cherciu, Nelly, Cho, Byoung Chul, Cicenas, Saulius, Cohen, Graham, Costa, Marcos Andre, De Angelis, Flavia, de Azevedo, Sergio Jobim, De Marchi, Pedro Rafael Martins, de The Bustamante Valles, Flor, Doganov, Boyan, Dreosti, Lydia, Duarte, Ricardo, Erman, Mustafa, Fein, Luis, Feng, Jifeng, Fenton, David, Fernandes, Gustavo, Ferreira, Carlos, Fujisaka, Yasuhito, Galvez, Christina, Gil, Nuno, Hall, Jacqueline, Hart, Gregory, He, Yong, Ho, Chung Man James, Horiike, Atsushi, Hu, Yi, Ichiki, Masao, Imamura, Fumio, Jassem, Jacek, Jordaan, Christa, Kaen, Diego, Katakami, Nobuyuki, Kato, Terufumi, Kawaguchi, Tomoya, Kim, Joo Hang, Kowalyszyn, Ruben, Ksienski, Doran, Kubota, Kaoru, Kuusk, Gerli, Laczo, Ibolya, Landers, Gregory, Lazarev, Sergey, Li, Wei, Liu, Zhe, Lopes, Valeria, Lu, Shun, Mas, Luis, Milanova, Zhasmina, Nakahara, Yasuharu, Ohman, Ronny, Ong, Choo Khoon, Ostoros, Gyula, Qin, Shukui, Ramlau, Rodryg, Richardet, Eduardo, Roubec, Jaromir, Rusyn, Andrii, Seki, Nobuhiko, Shimada, Andrea Kazumi, Shparyk, Yaroslav, Sinielnikov, Ivan, Soares, Joao Paulo Holanda, Stara, Zinaida, Tanaka, Hiroshi, Tang, Qiyou, Taranov, Pavel, Tejada, Hermes, Torii, Yoshitaro, Trukhyn, Dmytro, Turdean, Maria, Vera, Luis, Vynnychenko, Ihor, Wang, Jie, Wang, Kai, Yumuk, Fulden, Zambrano, Angela, Zemaitis, Marius, Zhao, Jun, Zhou, Jianying
Published in The Lancet (British edition) (04.05.2019)
Published in The Lancet (British edition) (04.05.2019)
Get full text
Journal Article
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Özgüroğlu, Mustafa, Mandalà, Mario, Ryu, Min-Hee, Olesiński, Tomasz, Mansoor, Wasat, Shacham-Shmueli, Einat, Chen, Xinqun, Kang, S Peter, Fuchs, Charles S, Lerzo, Guillermo, Lynam, James, Wong, Mark, Vasey, Paul, Van Laethem, Jean-Luc, Van Cutsem, Eric, Berry, Scott, Vincent, Mark, Muller, Bettina, Rey, Felipe, Zambrano, Angela, Guerra, Joaquin, Krogh, Merete, Yilmaz, Mette, Elme, Anneli, Auvinen, Paivi, Alanko, Tuomo, Moehler, Markus, Kunzmann, Volker, Hoehler, Thomas, Haag, Georg, Castro, Hugo, Aguilar Vasquez, Mynor, Cuffe, Sinead, Geva, Ravit, Hubert, Ayala, Beny, Alex, Giuseppe, Aprile, Passalacqua, Rodolfo, Montesarchio, Vincenzo, Chin, Keisho, Nishina, Tomohiro, Komatsu, Yoshito, Hironaka, Shuichi, Satoh, Taroh, Tamura, Takao, Sugimoto, Naotaoshi, Cho, Haruhiko, Omuro, Yashushi, Kato, Ken, Goto, Masahiro, Hyodo, Ichinosuke, Yoshida, Kazuhiro, Baba, Hideo, Esaki, Taito, Furuse, Junji, Wan Mohammed, Wan Zamaniah, Dominguez Andrade, Adriana, Glenjen, Nils, Kubiatowski, Tomasz, Jacek, Jassem, Wojtukiewicz, Marek, Lazarev, Sergey, Lancukhay, Yuri, Moiseyenko, Vladimir, Kostorov, Vladimir, Shirinkin, Vadim, Sakaeva, Dina, Fadeeva, Natalia, Yong, Wei Peng, Robertson, Barbara, Rapaport, Bernardo, Cohen, Graham, Dreosti, Lydia, Szpak, Waldemar, Roh, Sang-Young, Kim, Yeul Hong, Chung, Hyun Cheol, Ryu, Min-Hee, Longo Munoz, Federico, Cervantes Aguilar, Andres, Garcia Alfonso, Pilar, Feliu Batle, Jaime, Yeh, Kun-Huei, Chen, Jen-Shi, Chao, Yee, Kara, Oguz, Hochhauser, Daniel, Chau, Ian, Shaib, Walid, Philip, Philip, Sharma, Vivek, Sun, Weijing, George, Ben, Bullock, Andrea, Myrick, Samuel, Faruol, Josephine, Siegel, Richard, Becerra, Carlos, Richards, Donald A., Riche, Stephen L.
Published in The Lancet (British edition) (14.07.2018)
Published in The Lancet (British edition) (14.07.2018)
Get full text
Journal Article
Abstract CT036: Bioavailability of MK-3475A (pembrolizumab with berahyaluronidase alfa; “subcutaneous pembrolizumab”) in participants with advanced or metastatic solid tumors
Torras, Oscar Reig, Cohen, Graham, Cho, Byoung Chul, Rojas, Carlos, Walton, Cathryn, Medina, Laura, Khanyile, Richard, Papai, Zsuzsanna, Lala, Mallika, Song, Gina, Akala, Omobolaji, Coetzee, Corlia
Published in Cancer research (Chicago, Ill.) (25.04.2025)
Published in Cancer research (Chicago, Ill.) (25.04.2025)
Get full text
Journal Article
Abstract CT035: Pharmacokinetics (PK), safety, and tolerability of pembrolizumab with berahyaluronidase alfa administered subcutaneously Q3W in participants with advanced melanoma
Coetzee, Corlia, Khanyile, Richard, Cohen, Graham, McAdam, Georgina, Walton, Cathryn, Chan, Sze Wai, Rapoport, Bernardo, Caglevic, Christian, Yañez, Patricio, Lala, Mallika, Song, Gina, Cohen, Julia W., Rojas, Carlos
Published in Cancer research (Chicago, Ill.) (25.04.2025)
Published in Cancer research (Chicago, Ill.) (25.04.2025)
Get full text
Journal Article
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial
Powles, Thomas, Chang, Yen-Hwa, Yamamoto, Yoshiaki, Munoz, Jose, Reyes-Cosmelli, Felipe, Peer, Avivit, Cohen, Graham, Yu, Evan Y., Lorch, Anja, Bavle, Abhishek, Homet Moreno, Blanca, Markensohn, Julia, Edmondson, Mackenzie, Chen, Cai, Cristescu, Razvan, Peña, Carol, Lunceford, Jared, Gunduz, Seyda
Published in Nature medicine (01.09.2024)
Published in Nature medicine (01.09.2024)
Get full text
Journal Article
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma
Cohen, Graham, Rapoport, Bernardo, Chan, Sze W, Ruff, Paul, Arance, Ana, Mujika Eizmendi, Karmele, Houghton, Baerin, Brown, Michael P, Zielinski, Robert M, Muñoz Couselo, Eva, Lyle, Megan, Anderson, James R, Jain, Lokesh, de Alwis, Dinesh, Lala, Mallika, Akala, Omobolaji, Chartash, Elliot, Jacobs, Conrad
Published in PloS one (12.11.2024)
Published in PloS one (12.11.2024)
Get full text
Journal Article
Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the phase 3 KEYNOTE-361 trial
Chang, Wayne Yen-Hwa, Yamamoto, Yoshiaki, Muñoz-Langa, José, Reyes, Felipe, Peer, Avivit, Yu, Evan Y., Cohen, Graham, Lorch, Anja, Bavle, Abhishek, Homet Moreno, Blanca, Markensohn, Julia, Edmondson, Mackenzie, Chen, Cai, Cristescu, Razvan, Pena, Carol Elaine, Lunceford, Jared, Gunduz, Seyda
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Abstract CT143: Pembrolizumab bioavailability after subcutaneous administration: analysis from the KEYNOTE-555 Cohort A in metastatic melanoma
Jacobs, Conrad R., Rapoport, Bernardo Leon, Cohen, Graham Lawrence, Lala, Mallika, Silva, Carolina De Miranda, Vaddady, Pavan, Gheyas, Ferdous, de Alwis, Dinesh, Sinha, Vikram, Akala, Omobolaji Oyekunle, Chartash, Elliot, Jain, Lokesh
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
KEYNOTE-555 Cohort B: Efficacy, safety, and PK of pembrolizumab (pembro) 400 mg every 6 weeks (Q6W) as 1L therapy for advanced melanoma
Jacobs, Conrad R., Rapoport, Bernardo Leon, Chan, Sze Wai, Ruff, Paul, Arance, Ana Maria, Mujika, Karmele, Anderson, James Robert, Lala, Mallika, Jain, Lokesh, Akala, Omobolaji Oyekunle, Chartash, Elliot, Cohen, Graham Lawrence
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study
Graham Cohen, Bernardo Rapoport, Sze W. Chan, Paul Ruff, Ana Arance, Karmele Mujika Eizmendi, Baerin Houghton, Michael P. Brown, Robert M. Zielinski, Eva Muñoz Couselo, Megan Lyle, James R. Anderson, Lokesh Jain, Dinesh de Alwis, Mallika Lala, Omobolaji Akala, Elliot Chartash, Conrad Jacobs
Published in PloS one (01.01.2024)
Get full text
Published in PloS one (01.01.2024)
Journal Article
Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Maio, Michele, Lewis, Karl, Demidov, Lev, Mandalà, Mario, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Rutkowski, Piotr, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Yan, Yibing, Schadendorf, Dirk
Published in The lancet oncology (01.04.2018)
Published in The lancet oncology (01.04.2018)
Get full text
Journal Article
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Maio, Michele, Lewis, Karl, Demidov, Lev, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Cinat, Gabriela, Brown, Michael, Guminski, Alexander, Haydon, Andrew, Khattak, Adnan, McNeil, Catriona, Power, Jeremy, Roberts-Thomson, Rachel, Underhill, Craig, Berger, Thomas, Awada, Ahmad, Blockx, Nathalie, Buyse, Veronique, Mebis, Jeroen, Franke, Fábio André, Jobim de Azevedo, Sérgio, Silva Lazaretti, Nicolas, Mihalcioiu, Catalin, Petrella, Teresa, Song, Xinni, Wong, Ralph, Dabelic, Nina, Plestina, Stjepko, Vojnovic, Zeljko, Kocak, Ivo, Krajsova, Ivana, Kubala, Eugen, Melichar, Bohuslav, Dutriaux, Caroline, Joly, Pascal, Lacour, Jean-Philippe, Meyer, Nicolas, Mortier, Laurent, Fluck, Michael, Hassel, Jessica, Hauschild, Axel, Donnellan, Paul, McCaffrey, John, Power, Derek, Ariad, Samuel, Bar-Sela, Gil, Ron, Ilan, Schachter, Jacob, Berruti, Alfredo, Bianchi, Luca, Chiarion Sileni, Vanna, Cognetti, Francesco, Danielli, Riccardo, Di Giacomo, Anna Maria, Gianni, Luca, Goldhirsch, Aron, Guida, Michele, Maio, Michele, Mandalà, Mario, Marchetti, Paolo, Santoro, Armando, Kapiteijn, Ellen, Mackiewicz, Andrzej, Rutkowski, Piotr, Ferreira, Paula, Demidov, Lev, Gafton, Georgy, Makarova, Yulia, Jovanovic, Darjana, Kandolf Sekulovic, Lidija, Curiel Garcia, Maria Teresa, Majem Tarruella, Margarita, Marquez Rodas, Ivan, Puliats Rodriguez, Jose-M, Papworth, Karin, Bondarenko, Igor, Corrie, Pippa, Harries, Mark, Herbert, Christopher, Middleton, Mark, Patel, Poulam, Talbot, Toby, Agarwala, Sanjiv, Chapman, Paul, Conry, Robert, Doolittle, Gary, Gangadhar, Tara, Hallmeyer, Sigrun, Kass, Frederic, Lewis, Karl, Salama, April, Sikic, Branimir, Spigel, David, Whitman, Eric
Published in The lancet oncology (01.04.2018)
Published in The lancet oncology (01.04.2018)
Get full text
Journal Article
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial
Damaraju, Sambasivarao, Gorbunova, Vera, Gelmon, Karen A., Garcia Saenz, Jose Angel, Morales, Serafin, Abigerges, Dany Youssef, Canon, Jean-Luc, Lifirenko, Igor, Cohen, Graham Lawrence, Jerusalem, Guy Heinrich Maria, Thireau, Francois, Fresco, Rodrigo, Houé, Vincent, Press, Michael F., Narasimhan, Ashok, Mackey, John Robert
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article